Email Alert | RSS    帮助

中国防痨杂志 ›› 2005, Vol. 27 ›› Issue (2): 82-85.

• 论著 • 上一篇    下一篇

河南省结核病耐药监测中的经验教训

王国斌;徐吉英;彭义利;孙战强;王国杰;甄新安;李爱华;   

  1. 河南省结核病防治研究所 郑州 450003;
  • 出版日期:2005-02-10 发布日期:2005-11-03

Experiences and lessons on drug resistance surveillance of tuberculosis in Henan province

Wang Guobin, Xu Jiying, Peng Yili, et al.   

  1. Henan Provincial Anti-tuberculosis Research Institute,Zhengzhou 450003,China
  • Online:2005-02-10 Published:2005-11-03

摘要: 目的 回顾性分析河南省两轮结核病耐药监测(drug resistance sarvillence DRS)的经验教训,供开展DRS工作的同道参考、借鉴。方法 分析2次耐药监测总结资料和有关问题的专题报告,或查阅有关的实验数据;对主要问题作对比分析,列表统计;经主要参与者讨论提出经验教训或改进的建议。结果 (1)用药史不清可造成复治病例混入初治组,导致初始耐药率假性升高。故应对用药史分级复核,督导检查,培训时强调。(2)寒冷季节、地区运送痰标本加防腐剂溴化十六烷基吡啶(CPB),易出现结晶、培养不长与污染;改在县级直接作培养而不用CPB,可大量减少不生长与污染,并产生更大社会效益。(3)首次在县级作结核菌培养时,设备的检修、更新、供电的保证和应急措施,接种培养的严格技术培训都应先行充分准备以防止污染、烤干、不生长等问题。(4)DRS中出现对复治病例和少数初治病例的跳选。与培训讲解不清、错误理解或想减少工作量有关。加强培训教育和严格督导检查,及时发现、纠正跳选,才能保证标本代表性和科学性。(5)采用亮光源放大镜判读培养基上菌落并2人以上复核,以及用N·N-二甲基甲酰胺替代甲醇作利福平溶剂,制作药敏培养基,使初期质控结果的敏感性过高,特异性过低问题得以纠正,使之迅速达WHO合格标准。结论 重视并认真实施WHO《DRS指南》要求的三个原则——样本代表性,抗结核用药史准确性,实验室技术正确性与质控达标,是DRS动作成功的基础。

关键词: 结核, 耐药监测, 经验与教训

Abstract: Objective To analyze the experiences and lessons in two rounds of drug resistance surveillance in Henan province for reference to the colleagues who are going to do DRS. Methods Collected and analyzed the materials from the summarized report and special report in two rounds DRS in He’nan province. Then analyzed the main problems and lined it in the tables for comparing and statistics. After discussing, the main participated working staffs gave the ideas and suggestions. Results (1) If the drug using history was not clearly asked, it would miss categorized the retreatment cases into the initial treatment group, then it would increased the drug resistant rate of initial treatment group falsely. So it must be done that drug using history should be rechecked by different leaders or senior doctors in TB dispensary, supervised by specialists from WHO, national and provincial lab, and emphasized to doctors working in dispensary again during training . (2) In the cold season or area, if the CPB was put in sample of sputum as antiseptic, the crystal of CPB and no growth of TB, contamination of other bacteria would be presented in it obviously. When stopped putting CPB into sample of sputum and changed the place of TB culture to county lab of TB dispensary, the problems mentioned above disappeared almost, and the social benefit would be increased. (3) To prevent from contamination, no growth, and baking of culturing strains, a series of measures must be done before the starting of first DRS at the county dispensary, as follows: checking, repairing or renewing the equipments for TB culture setting, up new mesures for continuous supplement of electricity and technical training to technician of TB dispensary on TB culture. (4) It is necessary that to strengthen the training for leaders and doctors working in county TB dispensary and add the times of supervising of higher supervisors at the beginning so that to prevent from selecting TB patients irregularly and make the sample better representative. (5) Using bright light magloscope for colony counting and two persons or more for rechecking, and using N·N-dimethylformamide as a replacement for rifampicin solvent, we corrected the higher sensitivity and lower specificity in the beginning of DRS and soon it were up to standard of WHO. Conclusion Paying great attention to the three principles recommended by the WHO/IUATLD’S DRS guideline and practicing it seriously is the basement of making DRS success in any country, province or area. Our experiences and lessons on previous DRS presented above were also focused on it. Do remember and practice the three principles: sample must be representative, history of anti-TB drug used should be corrected, and lab technique should be qualified and up to standard of WHO/IUATLD.

Key words: Tuberculosis, Drug resistance surveillance (DRS), Experience and lesson